drugset / Trial / NCT03000127

Testosterone for Fatigue in Men With MS

NCT03000127

NaSingle-groupOpen-labelTreatment

Summary

Fatigue is a major symptom in people with multiple sclerosis (MS), for which treatments are limited. Several studies have shown that a large proportion of men with MS have low testosterone levels. We propose a two-site clinical trial using topical testosterone gel as a treatment for MS-related fatigue in men with progressive MS who have low or low-normal testosterone levels.

Timeline

Start
2018-07-01
Primary completion
2023-06-30
Completion
2024-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule Topical

Indications